ODU Digital Commonsmetadata only
Integrating Genetic Modifier Genotype With Serum Proteomics in Duchenne Muscular Dystrophy Clinical Trials Links LTBP4 Genetic Modifier to IL-23/CD93 Pathways in Muscle
biomarkers, clinical trials, duchenne muscular dystrophy, genetic polymorrphisms, genotype-phenotype correlation, inflammation—molecular mechanisms, muscle proteins—genetic aspects, pharmacogenomics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1001627
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.